Surprisingly, overexpression of Skp2 is associated with resistance and sensitization after pre-operative doxorubicin-based chemotherapeutically could aid in cancer cell death and successful chemotherapy in primary breast cancer patients (101, 102). The gene discussed is SKP2; the disease is breast carcinoma.